1. P604 Infection Risk in Elderly Patients with Inflammatory Bowel Disease under anti-TNF, ustekinumab or vedolizumab biologic therapies: A Prospective Multicenter observational One-Year follow-up comparative study. (21st January 2022) Authors: Bozon, A; Serrero, M; Caillo, L; Gilletta, C; Benezech, A; Nancey, S; Combes, R; Danan, G; Akouete, S; Pages, L; Bourgaux, J F; Boivineau, L; Meszaros, M; Altwegg, R Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i537 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗